ClinicalTrials.govpublic full text
CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma
leukemia, lymphoma, large b-cell, diffuse, leukemia, b-cell, lymphoma, b-cell, leukemia, lymphocytic, chronic, b-cell, lymphoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908827
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.